314 related articles for article (PubMed ID: 18043353)
1. Discrepancy between the dynamic computed tomography and T2 magnetic resonance perfusion imaging in brain tumors: a report of 2 cases.
Li YD; Geng DY; Zhang QB; Jiang SH
J Comput Assist Tomogr; 2007; 31(6):896-900. PubMed ID: 18043353
[TBL] [Abstract][Full Text] [Related]
2. [Cerebral Neurocytoma. Pictorial essay].
Fenchel M; Beschorner R; Korn A; Ernemann U; Horger M
Rofo; 2010 Sep; 182(9):737-40. PubMed ID: 20740400
[No Abstract] [Full Text] [Related]
3. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI.
Newman GC; Hospod FE; Patlak CS; Fain SE; Pulfer KA; Cook TD; O'Sullivan F
J Cereb Blood Flow Metab; 2006 Jun; 26(6):760-70. PubMed ID: 16319833
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
[TBL] [Abstract][Full Text] [Related]
5. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue.
Weber MA; Günther M; Lichy MP; Delorme S; Bongers A; Thilmann C; Essig M; Zuna I; Schad LR; Debus J; Schlemmer HP
Invest Radiol; 2003 Nov; 38(11):712-8. PubMed ID: 14566181
[TBL] [Abstract][Full Text] [Related]
6. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
Aprile I; Muti M; Principi M; Bartolini N; Zenoni A; Tazza G; Italiani M; Ottaviano P
Radiol Med; 2002; 104(1-2):87-91. PubMed ID: 12386559
[TBL] [Abstract][Full Text] [Related]
7. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
[TBL] [Abstract][Full Text] [Related]
8. Temporal evolution of MR perfusion in neonatal hypoxic-ischemic encephalopathy.
Wintermark P; Moessinger AC; Gudinchet F; Meuli R
J Magn Reson Imaging; 2008 Jun; 27(6):1229-34. PubMed ID: 18504740
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
[TBL] [Abstract][Full Text] [Related]
10. Echo-planar MR enters routine clinical practice.
Yamada K; Sorensen AG; Gonzalez G; Rosen BR
Diagn Imaging (San Franc); 1997 Nov; 19(11):195-201. PubMed ID: 10176115
[No Abstract] [Full Text] [Related]
11. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
Lüdemann L; Warmuth C; Plotkin M; Förschler A; Gutberlet M; Wust P; Amthauer H
Eur J Radiol; 2009 Jun; 70(3):465-74. PubMed ID: 18359598
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of brain function.
Turner R
Am J Physiol Imaging; 1992; 7(3-4):136-45. PubMed ID: 1343210
[TBL] [Abstract][Full Text] [Related]
13. Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis?
Lehmann P; Saliou G; de Marco G; Monet P; Souraya SE; Bruniau A; Vallée JN; Ducreux D
Eur J Radiol; 2012 Mar; 81(3):522-7. PubMed ID: 21334839
[TBL] [Abstract][Full Text] [Related]
14. [MR-based methods of the functional imaging of the central nervous system].
Giesel FL; Wüstenberg T; Bongers A; Weber MA; Zechmann C; Baudendistel KT; von Tengg-Kobligk H; Hahn HK; Essig M; Kauczor HU
Rofo; 2005 May; 177(5):714-30. PubMed ID: 15871087
[TBL] [Abstract][Full Text] [Related]
15. [T2*-contrast perfusion study--principles, theory and clinical utility in evaluating cerebral hemodynamics].
Ida M; Yamashita M; Shimizu S; Kurisu Y
Nihon Rinsho; 1997 Jul; 55(7):1719-25. PubMed ID: 9233015
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma.
Haris M; Husain N; Singh A; Husain M; Srivastava S; Srivastava C; Behari S; Rathore RK; Saksena S; Gupta RK
J Comput Assist Tomogr; 2008; 32(6):955-65. PubMed ID: 19204461
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-enhanced three-dimensional magnetization-prepared rapid gradient-echo (3D MP-RAGE) imaging is superior to spin-echo imaging in delineating brain metastases.
Takeda T; Takeda A; Nagaoka T; Kunieda E; Takemasa K; Watanabe M; Hatou T; Oguro S; Katayama M
Acta Radiol; 2008 Dec; 49(10):1167-73. PubMed ID: 18979271
[TBL] [Abstract][Full Text] [Related]
18. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
[TBL] [Abstract][Full Text] [Related]
19. Absolute blood contrast concentration and blood signal saturation on myocardial perfusion MRI: estimation from CT data.
Ishida M; Sakuma H; Murashima S; Nishida J; Senga M; Kobayasi S; Takeda K; Kato N
J Magn Reson Imaging; 2009 Jan; 29(1):205-10. PubMed ID: 19097094
[TBL] [Abstract][Full Text] [Related]
20. Computed tomography and magnetic resonance features of extraventricular neurocytoma: a study of eight cases.
Huang WY; Zhang BY; Geng DY; Zhang J
Clin Radiol; 2013 Apr; 68(4):e206-12. PubMed ID: 23332437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
